1-4 of 4
Robert Bird, MBBS
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

WT1 Expression Levels at Diagnosis and as a Marker of Minimal Residual Disease (MRD) in Patients with Acute Myeloid Leukaemia (AML).

James X Gray, MD, PhD, Lyle McMillen, PhD, Russell Saal, MMedSc, Steven Lane, MBBS, Peter Mollee, MBBS, Robert Bird, MBBS, Devinder Gill, MBChB, Paula Marlton, MBBS
Journal: Blood
Blood (2009) 114 (22): 2639.
https://doi.org/10.1182/blood.V114.22.2639.2639
Published: 2009
Journal Articles

JAK2 V617F Mutation Status Predicts Thrombotic Complications, Including Arterial Thrombosis, in Patients with Essential Thrombocytosis (ET).

Helen Weston, MBBS, Robert Bird, MBBS, Vanessa Griffiths, BSc, Mark Jones, BSc, PhD, Karen Grimmett, BSc, Russell Saal, BSc, Anthony K. Mills, MBBS, Devinder Gill, MBBS, Paula Marlton, MBBS, Peter Mollee, MBBS
Journal: Blood
Blood (2007) 110 (11): 2551.
https://doi.org/10.1182/blood.V110.11.2551.2551
Published: 2007
Journal Articles

Aggressive Cutaneous Squamous Cell Carcinoma (SCC) in Chronic Lymphocytic Leukaemia (CLL).

Steven W. Lane, MBBS, Peter N. Mollee, MBBS MMedSc, Robert Bird, MBBS, Sandro Porceddu, MBBS, Devinder Gill, MBBS
Journal: Blood
Blood (2005) 106 (11): 4993.
https://doi.org/10.1182/blood.V106.11.4993.4993
Published: 2005
Journal Articles

Accelerated Delivery of Rituximab Is Safe on an Out-Patient Basis.

Helen J. Middleton, MBBS, Peter Mollee, MBBS, Robert Bird, MBBS, Anthony K. Mills, MBBS, Paula Marlton, MBBS, Devinder Gill, MBBS
Journal: Blood
Blood (2005) 106 (11): 4777.
https://doi.org/10.1182/blood.V106.11.4777.4777
Published: 2005